Literature DB >> 11244391

Management of major depression in the primary care setting.

D Mischoulon1, R McColl-Vuolo, S Howarth, I T Lagomasino, J E Alpert, A A Nierenberg, M Fava.   

Abstract

BACKGROUND: Patients treated in community clinics, particularly those of minority status, may rely more heavily on primary care physicians (PCPs) for the diagnosis and management of depression. We wished to determine how PCPs in a community clinic setting initially manage patients newly diagnosed with major depression.
METHODS: 698 patients were screened for major depression by the Structural Clinical Interview for DSM-III-R in a community-based primary care health center. Forty outpatients (29 Hispanic) were found to suffer from major depression. A letter explaining positive findings was sent to the patients' PCPs. Medical record charts were reviewed 3 months later to determine the PCP's management following the diagnosis.
RESULTS: Of the 38 patients who remained in the study at 3 months, 20 (53%) received no intervention from the PCP by the end of 3 months after diagnosis, and of these, 14 were Hispanic. Five (13%) were prescribed an antidepressant by the PCP. Nine (24%) were referred to mental health services for medication, psychotherapy or combination treatment. Four (11%) were prescribed an antidepressant and then referred to mental health services. Differences between management of Hispanic and non-Hispanic patients were not statistically significant.
CONCLUSIONS: Independent screening by psychiatrists in primary care settings may not be adequate enough to ensure appropriate management of depression by PCPs. Possible explanations may include time constraints during primary care visits, patient and/or physician reticence, and insufficient education of PCPs about depression. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244391     DOI: 10.1159/000056233

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  4 in total

1.  A method for rating charts to identify and classify patients with medically unexplained symptoms.

Authors:  Robert C Smith; Elie Korban; Mohammed Kanj; Robert Haddad; Judith S Lyles; Catherine Lein; Joseph C Gardiner; Annemarie Hodges; Francesca C Dwamena; John Coffey; Clare Collins
Journal:  Psychother Psychosom       Date:  2004 Jan-Feb       Impact factor: 17.659

2.  Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.

Authors:  David Mischoulon; Stefania Lamon-Fava; Jacob Selhub; Judith Katz; George I Papakostas; Dan V Iosifescu; Albert S Yeung; Christina M Dording; Amy H Farabaugh; Alisabet J Clain; Lee Baer; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Journal:  CNS Spectr       Date:  2012-06       Impact factor: 3.790

3.  A study of a culturally focused psychiatric consultation service for Asian American and Latino American primary care patients with depression.

Authors:  Nhi-Ha T Trinh; C A Bedoya; Trina E Chang; Katherine Flaherty; Maurizio Fava; Albert Yeung
Journal:  BMC Psychiatry       Date:  2011-10-13       Impact factor: 3.630

Review 4.  Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.

Authors:  Giovanni A Fava; Chiara Ruini; Nicoletta Sonino
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.